Who is sponsoring NCT04856956?

NCT04856956 is sponsored by PhenoSolve, LLC.

What drugs are being tested in NCT04856956?

Interventions in NCT04856956: Diagnostic decision support software.

What condition does NCT04856956 study?

NCT04856956 studies Diagnostic Skills for Rheumatologic Conditions.

Is NCT04856956 still recruiting?

NCT04856956 is currently status unknown. Last updated 4 October 2022.

Last reviewed 2022-10-04 · How we verify

NCT04856956

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Testing Pediatric Rheumatology Diagnostic Decision Support in Clinical Use

Status unknown NA Last updated 4 October 2022

What this trial tests

NA trial testing Diagnostic decision support software in Diagnostic Skills for Rheumatologic Conditions in 15 participants. Status unknown.

Timeline

20 April 2021

Primary endpoint
31 December 2023

31 December 2023

Quick facts

Lead sponsor	PhenoSolve, LLC
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	diagnostic
Enrollment	15
Start date	20 April 2021
Primary completion	31 December 2023
Estimated completion	31 December 2023
Sites	1 location across United States

Drugs / interventions tested

Diagnostic decision support software

Conditions studied

Diagnostic Skills for Rheumatologic Conditions — all drugs for Diagnostic Skills for Rheumatologic Conditions →

Sponsor

PhenoSolve, LLC — full company profile →

Who can join

Adults 18 to 65, any sex, with Diagnostic Skills for Rheumatologic Conditions. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is designed to test the helpfulness of a diagnostic tool, SimulConsult, when clinicians are diagnosing pediatric rheumatic diseases. Trainees and nurse practitioners will use the software or not use it, and their differential diagnoses will be compared to those of attending physicians in the same clinical encounter, and then to definitive diagnoses weeks later after testing, if one is reached.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other PhenoSolve, LLC trials

Trials by the same sponsor.

NCT03676725 — Prevalence of Lidocaine Ineffectiveness in Adults With and Without ADHD · EARLY_PHASE1 · completed
NCT03680885 — Validating a New Non-invasive Approach to Testing Lidocaine Effectiveness · EARLY_PHASE1 · completed
NCT04167189 — Observational Study to Assess the Frequency of Lidocaine Ineffectiveness in Hard-to-treat ADHD · EARLY_PHASE1 · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04856956 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by PhenoSolve, LLC
Last refreshed: 4 October 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04856956.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing